Patents by Inventor Esther M. Valliant

Esther M. Valliant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT
    Publication number: 20240002549
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 4, 2024
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, JR., Andrew C. Yang
  • Reactive polysaccharide-based hemostatic agent
    Patent number: 11739166
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: August 29, 2023
    Assignee: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, Jr., Andrew C. Yang
  • FLOWABLE HEMOSTATIC SUSPENSION
    Publication number: 20220001075
    Abstract: Compositions and methods related to flowable hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Frederick H. Strickler, JR., Andrew C. Yang, Rajendra R. Bhat, Jessica Powell, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant
  • REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT
    Publication number: 20220002444
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, JR., Andrew C. Yang